Figure 1.

Graphic summary of the emerging drug targets for the treatment of COVID-19. The pharmacological targets (white text boxes) and the relative proposed drugs (light blue text boxes) are noted. Abbreviations: ACE2, angiotensin converting enzyme 2; TMPRSS2, type 2 transmembrane serine protease; S protein, spike protein; 3CLPro, 3-chymotripsin like protease; RdRp, RNA dependent RNA polymerase; IL-6, interleukin 6; IL-6R, interleukin 6 receptor; IL-1β, interleukin 1 beta; NLRP3, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3. Images from Smart Servier Medical Art (https://smart.servier.com/) have been combined for creating the illustration. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).